Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Carisma Therapeutics Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CARM is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 33
- −3 vs. Q2 2025
- Shares held
- 3.08M
- −906.5K (−22.8%) vs. Q2 2025
- Total value
- $842.6K
- −$714.4K (−45.9%) vs. Q2 2025
- New holders
- 3
- 2 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 3 | $47.9K |
| Q4 2025 | 7 | $67.0K |
| Q3 2025 | 33 | $842.6K |
| Q2 2025 | 36 | $1.56M |
| Q1 2025 | 37 | $1.73M |
| Q4 2024 | 41 | $2.35M |
| Q3 2024 | 37 | $5.11M |
| Q2 2024 | 53 | $9.28M |
| Q1 2024 | 51 | $19.3M |
| Q4 2023 | 50 | $26.4M |
| Q3 2023 | 58 | $39.6M |
| Q2 2023 | 53 | $84.0M |
| Q1 2023 | 37 | $17.3M |
| Q4 2022 | 71 | $19.8M |
| Q3 2022 | 69 | $11.0M |
| Q2 2022 | 74 | $23.1M |
| Q1 2022 | 84 | $26.4M |
| Q4 2021 | 93 | $39.1M |
| Q3 2021 | 103 | $44.5M |
| Q2 2021 | 106 | $305.9M |
| Q1 2021 | 76 | $104.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 32 | $0 | 0.00% | +32 | New |
| Jones Financial Companies LLLP | 16 | $5 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 37 | $10 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 50 | $13 | 0.00% | 00.0% | Unchanged |
| Medallion Wealth Advisors, LLC | 100 | $27 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 142 | $29 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 107 | $29 | 0.00% | −25−18.9% | Reduced |
| Carolina Wealth Advisors, LLC | 150 | $41 | 0.00% | 00.0% | Unchanged |
| ORG Partners LLC | 200 | $54 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 206 | $56 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 347 | $95 | 0.00% | 00.0% | Unchanged |
| Union Bancaire Privee, UBP SA | 535 | $131 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 921 | $252 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,398 | $383 | 0.00% | +63+4.7% | Added |
| Group One Trading, L.P. | 2,230 | $611 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,185 | $873 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,032 | $1.93K | 0.00% | −15,073−68.2% | Reduced |
| Citigroup Inc | 11,274 | $3.09K | 0.00% | +11,274 | New |
| Two Sigma Securities, LLC | 12,828 | $3.52K | 0.00% | −5,124−28.5% | Reduced |
| Dynamic Financial Group | 15,350 | $4.21K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 16,410 | $4.50K | 0.00% | +3,384+26.0% | Added |
| Virtu Financial LLC | 22,854 | $6.00K | 0.00% | +22,854 | New |
| Blodgett Wealth Advisors, LLC | 24,001 | $6.58K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 30,988 | $8.49K | 0.00% | 00.0% | Unchanged |
| Empowered Funds, LLC | 30,988 | $8.49K | 0.00% | 00.0% | Unchanged |
| GTS Securities LLC | 50,118 | $13.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 55,039 | $15.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 85,106 | $23.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 250,495 | $68.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 293,686 | $80.5K | 0.00% | −35,600−10.8% | Reduced |
| BlackRock, Inc. | 336,789 | $92.3K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 350,324 | $96.0K | 0.00% | 00.0% | Unchanged |
| Merck & Co., Inc. | 1,473,240 | $403.7K | 0.18% | 00.0% | Unchanged |
| AJU IB Investment Co., Ltd. | 0 | $0 | 0.00% | −718,332−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −150,810−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −18,404−100.0% | Sold out |
| Bank & Trust Co | 0 | $0 | 0.00% | −525−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −75−100.0% | Sold out |